| 25.04.2024 12:19 | GAL, HEMO, AERI | EARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payout | Alliance |
| 25.04.2024 07:00 | HEMO | Final Results | RNS |
| 28.03.2024 07:00 | HEMO | Total Voting Rights | RNS |
| 29.02.2024 14:04 | HEMO | Hemogenyx Pharmaceuticals raises money for leukaemia treatment | Alliance |
| 29.02.2024 07:00 | HEMO | Placing to Raise US$4.2 million | RNS |
| 16.02.2024 11:27 | HEMO | Hemogenyx shares rise on potential for CBR to treat brain diseases | Alliance |
| 16.02.2024 07:00 | HEMO | CBR Brain Delivery | RNS |
| 14.02.2024 10:14 | HEMO | Hemogenyx says CBR can be used intranasally to treat viral infections | Alliance |
| 14.02.2024 07:00 | HEMO | CBR Intranasal Delivery | RNS |
| 09.02.2024 10:00 | HEMO | IN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial hold | Alliance |
| 02.02.2024 10:44 | HEMO | IN BRIEF: Hemogenyx hails US patent application progress | Alliance |
| 16.01.2024 11:13 | HEMO | Hemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDA | Alliance |
| 16.01.2024 07:00 | HEMO | Submission of Complete Response to Clinical Hold | RNS |
| 08.01.2024 10:56 | HEMO | Hemogenyx Pharmaceuticals completes process qualification run | Alliance |
| 08.01.2024 07:00 | HEMO | HEMO-CAR-T Process Qualification Run Completed | RNS |
| 28.11.2023 16:53 | HEMO, UPL, FDP | TRADING UPDATES: Upland Resources completes technical study at Sarawak | Alliance |
| 28.11.2023 12:19 | HEMO | Placing to Raise £534,375 | RNS |
| 27.11.2023 10:52 | HEMO | Hemogenyx shares up as says CBR platform a potential cancer treatment | Alliance |
| 27.11.2023 07:00 | HEMO | CBR Expanded to Treatment of Cancer | RNS |
| 15.11.2023 15:43 | HEMO | Hemogenyx Pharmaceuticals completes lentivirus re-manufacture | Alliance |
| 15.11.2023 07:00 | HEMO | Lentivirus Re-manufacturing Completed | RNS |
| 31.10.2023 07:00 | HEMO | Total Voting Rights | RNS |
| 28.09.2023 14:24 | DAR, NSCI, MET1 | EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens | Alliance |
| 28.09.2023 12:28 | HEMO | Half-year Report | RNS |
| 18.09.2023 14:37 | HEMO, CRTM, BSFA | TRADING UPDATES: Avingtrans buys Adaptix, TPXimpact sells Questers | Alliance |
| 18.09.2023 07:00 | HEMO | Strategic Investment from Prevail Partners, LLC | RNS |
| 14.09.2023 14:31 | HEMO | Hemogenyx Pharma says US FDA accepts Hemo-Car-T clinical hold lift plan | Alliance |
| 14.09.2023 07:00 | HEMO | Clinical Hold Lift Plan is accepted by FDA | RNS |
| 08.09.2023 19:43 | HEMO | IN BRIEF: Hemogenyx Pharmaceuticals says patent number published | Alliance |
| 08.09.2023 17:11 | HEMO | CBR Patent Application Update | Reach |
| 10.07.2023 10:27 | HEMO | Hemogenyx says Hemo-Car-T treatment placed on clinical hold by US FDA | Alliance |
| 10.07.2023 07:00 | HEMO | Full FDA Review for HEMO-CAR-T IND | RNS |
| 30.06.2023 16:07 | HEMO | Result of Annual General Meeting | RNS |
| 23.06.2023 15:51 | CHSS, URAH, STG | UK shareholder meetings calendar - next 7 days | Alliance |
| 02.06.2023 14:01 | HEMO | Posting of Annual Report & Notice of AGM | RNS |
| 02.06.2023 13:08 | HEMO | IN BRIEF: Hemogenyx announces clinical hold for Hemo-Car-T treatment | Alliance |
| 02.06.2023 11:24 | HEMO | Clinical Hold on IND for HEMO-CAR-T | RNS |
| 09.05.2023 15:16 | HEMO | IN BRIEF: Hemogenyx submits FDA application for Hemo-Car-T treatment | Alliance |
| 09.05.2023 07:00 | HEMO | Submission of IND for HEMO-CAR-T | RNS |
| 28.04.2023 15:35 | HEMO, LSAA, CHF | EARNINGS SUMMARY: DP Aircraft profit swing, Chesterfield loss widens | Alliance |
| 28.04.2023 10:05 | HEMO | Equity Incentive Pool Increase and Option Grant | RNS |
| 28.04.2023 07:00 | HEMO | Final Results for the Year Ended 31 December 2022 | RNS |
| 23.03.2023 20:32 | RKH, HEMO, FPP | TRADING UPDATES: Fragrant Prosperity to buy Hi 55, Oscillate talks end | Alliance |
| 23.03.2023 13:32 | HEMO | HEMO-CAR-T Analytical Release Tests Completed | Reach |
| 28.02.2023 07:00 | HEMO | Total Voting Rights | RNS |
| 07.02.2023 14:30 | HEMO | Admission of Shares to Official List | RNS |
| 26.01.2023 10:45 | HEMO | Hemogenyx raises GBP4 million in share placing for Hemo-CAR-T product | Alliance |
| 26.01.2023 09:05 | HEMO | Second Price Monitoring Extn | RNS |
| 26.01.2023 09:00 | HEMO | Price Monitoring Extension | RNS |
| 26.01.2023 07:00 | HEMO | Placing to Raise £4,056,250 | RNS |
| 23.01.2023 16:59 | HEMO | IN BRIEF: Hemogenyx completes process run for HEMO-CAR-T manufacture | Alliance |
| 23.01.2023 07:00 | HEMO | HEMO-CAR-T 3rd Process Qualification Run Completed | Reach |
| 16.01.2023 16:40 | HEMO | Second Price Monitoring Extn | RNS |
| 16.01.2023 16:35 | HEMO | Price Monitoring Extension | RNS |
| 13.01.2023 11:05 | HEMO | Second Price Monitoring Extn | RNS |
| 13.01.2023 11:00 | HEMO | Price Monitoring Extension | RNS |
| 12.01.2023 16:40 | HEMO | Second Price Monitoring Extn | RNS |
| 12.01.2023 16:35 | HEMO | Price Monitoring Extension | RNS |
| 12.01.2023 14:05 | HEMO | Second Price Monitoring Extn | RNS |
| 12.01.2023 14:00 | HEMO | Price Monitoring Extension | RNS |
| 10.01.2023 16:35 | HEMO | Price Monitoring Extension | RNS |
| 09.01.2023 10:21 | HEMO | Hemogenyx shares up on single target protein virus treatment finding | Alliance |
| 09.01.2023 09:05 | HEMO | Second Price Monitoring Extn | RNS |
| 09.01.2023 09:00 | HEMO | Price Monitoring Extension | RNS |
| 09.01.2023 07:00 | HEMO | Single CBR Can Treat Multiple Viruses | Reach |
| 05.01.2023 16:40 | HEMO | Second Price Monitoring Extn | RNS |
| 05.01.2023 16:35 | HEMO | Price Monitoring Extension | RNS |
| 05.01.2023 11:05 | HEMO | Second Price Monitoring Extn | RNS |
| 05.01.2023 11:00 | HEMO | Price Monitoring Extension | RNS |
| 04.01.2023 11:12 | HEMO | IN BRIEF: Hemogenyx Pharma second process qualification run successful | Alliance |
| 04.01.2023 10:36 | HEMO, HEIQ | SMALL-CAP WINNERS & LOSERS: HeiQ drops on expectation of lower sales | Alliance |
| 04.01.2023 07:00 | HEMO | HEMO-CAR-T Process Qualification Run Completed | Reach |
| 12.12.2022 07:00 | HEMO | HEMO-CAR-T First PQ Run Completed | Reach |
| 18.11.2022 16:21 | HEMO | Hemogenyx makes final development run of HEMO-CAR-T cell manufacture | Alliance |
| 18.11.2022 15:19 | HEMO | HEMO-CAR-T Process Development Runs Completed | Reach |
